Intra-Articular Depot Formulation Principles: Role in the Management of Postoperative Pain and Arthritic Disorders

被引:237
作者
Larsen, Claus [1 ]
Ostergaard, Jesper [1 ]
Larsen, Susan W. [1 ]
Jensen, Henrik [1 ]
Jacobsen, Stine [2 ]
Lindegaard, Casper [2 ]
Andersen, Pia H. [2 ]
机构
[1] Univ Copenhagen, Fac Pharmaceut Sci, Dept Pharmaceut & Analyt Chem, DK-2100 Copenhagen, Denmark
[2] Univ Copenhagen, Fac Life Sci, Dept Large Anim Sci, DK-1870 Copenhagen, Denmark
关键词
controlled release/delivery; distribution; drug delivery system; formulation; intra-articular; osteoarthritis; parenteral depot formulation; postoperative pain; rheumatoid arthritis; targeted drug delivery;
D O I
10.1002/jps.21346
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The joint cavity constitutes a discrete anatomical compartment that allows for local drug action after intra-articular injection. Drug delivery systems providing local prolonged drug action are warranted in the management of postoperative pain and not least arthritic disorders such as osteoarthritis. The present review surveys various themes related to the accomplishment of the correct timing of the events leading to optimal drug action in the joint space over a desired time period. This includes a brief account on (patho)physiological conditions and novel potential drug targets (and their location within the synovial space). Particular emphasis is paid to W the potential feasibility of various depot formulation principles for the intra-articular route of administration including their manufacture, drug release characteristics and in vivo fate, and (ii) how release, mass transfer and equilibrium processes may affect the intra-articular residence time and concentration of the active species at the ultimate receptor site. (C) 2008 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 97:4622-4654, 2008
引用
收藏
页码:4622 / 4654
页数:33
相关论文
共 335 条
[1]  
Abe Tomoyuki, 2003, J Orthop Sci, V8, P92, DOI 10.1007/s007760300016
[2]   Drug delivery in degenerative joint disease: Where we are and where to go? [J].
Abramson, S .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (02) :125-127
[3]   Biologics in development for rheumatoid arthritis: Relevance to osteoarthritis [J].
Abramson, Steven B. ;
Yazici, Yusuf .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (02) :212-225
[4]   Prospects for disease modification in osteoarthritis [J].
Abramson, Steven B. ;
Attur, Mukundan ;
Yazici, Yusuf .
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2006, 2 (06) :304-312
[5]   Role of adhesion molecules in synovial inflammation [J].
Agarwal, Sandeep K. ;
Brenner, Michael B. .
CURRENT OPINION IN RHEUMATOLOGY, 2006, 18 (03) :268-276
[6]   Osteoarthritis: Pathobiology-targets and ways for therapeutic intervention [J].
Aigner, T. ;
Sachse, A. ;
Gebhard, P. M. ;
Roach, H. I. .
ADVANCED DRUG DELIVERY REVIEWS, 2006, 58 (02) :128-149
[7]   Collagens -: major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair [J].
Aigner, T ;
Stöve, J .
ADVANCED DRUG DELIVERY REVIEWS, 2003, 55 (12) :1569-1593
[8]  
AKERS M J, 1987, Journal of Parenteral Science and Technology, V41, P88
[9]  
[Anonymous], 1980, JOINTS SYNOVIAL FLUI
[10]  
Badger AM, 2001, ARTHRITIS RHEUM-US, V44, P128, DOI 10.1002/1529-0131(200101)44:1<128::AID-ANR17>3.0.CO